Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease

Canadian Journal of Neurological Sciences

Volumn 34, Issue 4, 2007, Pages 438-442

  De Bie, R M A ^a,b   Miyasaki, J ^a   Lang, A E ^a   Fox, S H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEMOGRAPHY; DRIVING ABILITY; DRUG USE; HEALTH SURVEY; HUMAN; INFORMATION SERVICE; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SLEEP; STATISTICAL SIGNIFICANCE;

EID: 37049031251     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100007320     Document Type: Article

References (17)

1. Moller H. Antiparkinsonian drugs and "sleep attacks." Canadian ADR newsletter. 2001;11:3-4.
2. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology. 1999;52:1908-10.
3. Olanow CW, Schapira AHV, Roth T. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole [letter]. Neurology. 2000;54:274.
4. Weiner WJ. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole [letter]. Neurology. 2000;54:274-5.
5. Uc EY, Rizzo M, Anderson SW, Sparks JD, Rodnitzky RL, Dawson JD. Impaired visual search in drivers with Parkinson's disease. Ann Neurol. 2006;60:407-13.
6. Homann CN, Suppan K, Homann B, Crevenna R, Ivanic G, Ruzicka E. Driving in Parkinson's disease - a health hazard? J Neurol. 2003;250:1439-46.
7. Ritter G, Steinberg H. Parkinsonism and driving fitness. Munch Med Wochenschr. 1979;121:1329-30.
8. Bassi S, Albizzati MG, Frattola L, Passerini D, Trabucchi M. Dopamine receptors and sleep induction in man. J Neurol Neurosurg Psychiatry. 1997;42:458-60.
9. Ferreira JJ, Galitzky M, Thalamas C, Tiberge M, Montastruc JL, 7 Sampaio C, et al. Effect of ropinirole on sleep onset: a randomized placebo controlled study in healthy volunteers. Neurology. 2002;58:460-2.
10. Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease. Is it the drug or the disease? Neurology. 2006;67:853-8.
11. Hobson DE, Lang AE, Martin WRW, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. A survey by the Canadian Movement Disorders Group. JAMA. 2002;287:455-63.
12. Clarenbach P. Parkinson's disease and sleep. J Neurol. 2000;247(Suppl):20-3.
13. Schafer D, Greulich W. Effects of parkinsonian medication on sleep. J Neurol. 2000;247 Suppl:24-7.
14. Bowen FP, Kamienny RS, Burns MM, Yahr M. Parkinsonism: effects of levodopa treatment on concept formation. Neurology. 1975;25:701-4.
15. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW. Impaired extra-dimensial shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia. 1989;27:1329-43.
16. Kulisevsky J, Garcia-Sanchez C, Berthier ML, Barbanoj M, Pascual-Sedano B, Gironeil A, et al. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Mov Disord. 2000;15:613-26.
17. Nabi H, Guéguen A, Chiron M, Lafont S, Zins M, Lagarde E. Awareness of driving while sleepy and road traffic accidents: prospective study in GAZEL cohort. BMJ. 2006;333:75-7.